Article
Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Apr 2010
Le Deley Marie-Cecile, Delattre Olivier, Schaefer Karl-Ludwig, Burchill Sue A, Koehler Gabriele, Hogendoorn Pancras C W, Lion Thomas, Poremba Christopher, Marandet Julien, Ballet Stelly, Pierron Gaelle, Brownhill Samantha C, Nesslböck Michaela, Ranft Andreas, Dirksen Uta, Oberlin Odile, Lewis Ian J, Craft Alan W, Jürgens Heribert, Kovar Heinrich
Abstract excerpt
PURPOSE EWS-ETS fusion genes are the driving force in Ewing's sarcoma pathogenesis. Because of the variable breakpoint locations in the involved genes, there is heterogeneity in fusion RNA and protein architecture. Since previous retrospective studies suggested prognostic differences among patien...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
